Allen King is a seasoned pharmaceutical executive with over 15 years of experience in pricing and market access. He is a go-to expert in developing payer-centric clinical trial designs to support US and EU markets product launches. King has demonstrated his proficiency in building pricing and market access functions from the ground up, making him one of the top leaders in the field. He has worked for prestige pharmaceutical companies such as Bristol-Myers Squibb, Astrazeneca, Wyeth Pharmaceuticals, and GE Healthcare, where he led numerous global market access strategies.

King's leadership style is built on trust and autonomy. He sets up a vision that aligns with the product or disease area strategy and allows the team to perform based on their unique talent. He specializes in global market access strategy, health economics, and pricing, payer research design, and implementation, making him one of the best in his profession. His passion for market access stems from the need to translate excellent science into a valuable proposition that can answer the payer's questions.